Texas Instruments Incorporated (NASDAQ: TXN) beat revenue and earnings estimates for the fourth quarter of 2019. Shares were down 0.66% in aftermarket hours on Wednesday.
Total revenues fell 10% to $3.35 billion versus the year-ago period but topped estimates of $3.21 billion.
Net income dropped 14% year-over-year to $1.07 billion while EPS fell 12% to $1.12. Adjusted EPS amounted to $1.11. Analysts had forecast EPS of $1.01.
During the quarter, the company saw revenue decreases across all its segments. Revenue in Analog fell 5% hurt by declines in Signal Chain, High Volume and Power. In Embedded Processing, revenue fell 20% mainly due to Processors. In the Other segment, revenue fell 24%.
For the first quarter of 2020, Texas Instruments expects revenue in the range of $3.12 billion to $3.38 billion, and EPS to be between $0.96 and $1.14, which includes an estimated $20 million discrete tax benefit.
Over the past one year, the stock has gained over 39% and over the past three months, it has gained 12%.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications
